These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33073697)

  • 1. Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6.
    Zhong D; Lyu X; Fu X; Xie P; Liu M; He F; Huang G
    Technol Cancer Res Treat; 2020; 19():1533033820967473. PubMed ID: 33073697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-186 Represses Proliferation, Migration, Invasion, and EMT of Hepatocellular Carcinoma via Directly Targeting CDK6.
    Lu J; Zhao Z; Ma Y
    Oncol Res; 2020 Dec; 28(5):509-518. PubMed ID: 32698940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
    Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
    Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-1178-3p suppresses the growth of hepatocellular carcinoma by regulating transducin (beta)-like 1 X-linked receptor 1.
    Pan Q; Shao Z; Zhang Y; Liu H
    Hum Cell; 2021 Sep; 34(5):1466-1477. PubMed ID: 34125401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6.
    Zhu H; Wang G; Zhou X; Song X; Gao H; Ma C; Chang H; Li H; Liu FF; Lu J; Ma J
    Biomed Pharmacother; 2016 Oct; 83():792-797. PubMed ID: 27490780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q; Zhang W; Wang Z; Liu S
    BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
    Zhao X; Chen GQ; Cao GM
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
    Chen S; Wang L; Yao B; Liu Q; Guo C
    Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-455-3p functions as a tumor suppressor by targeting HDAC2 to regulate cell cycle in hepatocellular carcinoma.
    Ma F; Huang J; Li W; Li P; Liu M; Xue H
    Environ Toxicol; 2022 Jul; 37(7):1675-1685. PubMed ID: 35286011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-935 Promotes Liver Cancer Cell Proliferation and Migration by Targeting SOX7.
    Liu X; Li J; Yu Z; Li J; Sun R; Kan Q
    Oncol Res; 2017 Mar; 25(3):427-435. PubMed ID: 27697092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00205, a YY1-modulated lncRNA, serves as a sponge for miR-26a-5p facilitating the proliferation of hepatocellular carcinoma cells by elevating CDK6.
    Cheng T; Yao Y; Zhang S; Zhang XN; Zhang AH; Yang W; Hou CZ
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6208-6219. PubMed ID: 34730201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis.
    Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X
    J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
    Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
    Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression.
    Leong KW; Cheng CW; Wong CM; Ng IO; Kwong YL; Tse E
    Oncotarget; 2017 Feb; 8(7):11343-11355. PubMed ID: 28076852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5.
    Yao B; Li Y; Niu Y; Wang L; Chen T; Guo C; Liu Q
    J Cell Mol Med; 2020 Aug; 24(15):8718-8731. PubMed ID: 32596968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
    Wang G; Sun Y; He Y; Ji C; Hu B; Sun Y
    Int J Clin Exp Pathol; 2015; 8(1):337-44. PubMed ID: 25755720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
    Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00152 promotes cell cycle progression in hepatocellular carcinoma via miR-193a/b-3p/CCND1 axis.
    Ma P; Wang H; Sun J; Liu H; Zheng C; Zhou X; Lu Z
    Cell Cycle; 2018; 17(8):974-984. PubMed ID: 29895195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.